| # | Drug | Count |
|---|---|---|
| 0 | GIVOSIRAN SODIUM | 495 |
| 1 | DICLOFENAC SODIUM | 377 |
| 2 | DICLOFENAC | 369 |
| 3 | ADALIMUMAB | 353 |
| 4 | LEFLUNOMIDE | 353 |
| 5 | RITUXIMAB | 346 |
| 6 | ACETAMINOPHEN | 341 |
| 7 | DICLOFENAC SODIUM 1% | 337 |
| 8 | DICLOFENAC SODIUM TOPICAL | 337 |
| 9 | DICLOFENAC SODIUM TOPICAL GEL, 1% | 337 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GIVOSIRAN SODIUM | 495 | 0.3175 |
| 1 | HEMIN | 67 | 0.1126 |
| 2 | WHITE PETROLATUM MINERAL OIL | 2 | 0.0690 |
| 3 | CAFFEINE CITRATE | 104 | 0.0446 |
| 4 | HYDROCORTISONE BUTYRATE | 87 | 0.0440 |
| 5 | HYDROCORTISONE SODIUM SUCCINATE | 162 | 0.0406 |
| 6 | RITUXIMAB AND HYALURONIDASE | 17 | 0.0375 |
| 7 | DICLOFENAC POTASSIUM TABLETS | 277 | 0.0319 |
| 8 | NEOMYCIN OINTMENT | 72 | 0.0294 |
| 9 | CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL | 9 | 0.0293 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 479 |
| 1 | Corticosteroid [EPC] | 436 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 388 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 354 |
| 4 | Antirheumatic Agent [EPC] | 353 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 344 |
| 6 | Vitamin C [EPC] | 344 |
| 7 | Benzodiazepine [EPC] | 326 |
| 8 | Interleukin-17A Antagonist [EPC] | 326 |
| 9 | Aminosalicylate [EPC] | 319 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 59 | 0.0858 |
| 1 | Endoglycosidase [EPC] | 136 | 0.0734 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 216 | 0.0248 |
| 3 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 8 | 0.0097 |
| 4 | Provitamin D2 Compound [EPC] | 263 | 0.0088 |
| 5 | Interleukin-17A Antagonist [EPC] | 326 | 0.0087 |
| 6 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 7 | Antirheumatic Agent [EPC] | 353 | 0.0033 |
| 8 | Aminosalicylate [EPC] | 319 | 0.0032 |
| 9 | Methylxanthine [EPC] | 183 | 0.0031 |